<!DOCTYPE>
<html>
<head>
<meta charset="UTF-8">
<meta http-equiv="Content-Type" content="text/html; charset=utf-8"> 
<meta name="viewport" content="width=1024"> 
<meta name="viewport" content="initial-scale = 1.0, user-scalable = yes, maximum-scale = 2.0"> 
<meta name="apple-mobile-web-app-capable" content="yes"> 
<meta name="apple-mobile-web-app-status-bar-style" content="black-translucent"> 
<meta name="format-detection" content="telephone=no">

<title>ACCP</title>
<link rel="stylesheet" type="text/css" href="css/style.css">
<link rel="stylesheet" type="text/css" href="css/bootstrap.min.css">
<script type="text/javascript" src="js/jquery.js"></script>

<script type="text/javascript">
$(document).ready(function() { 

});
</script> 

</head>

<body>

    <h1 class="main_title">Management</h1>
    
    <div class="col-xs-12 col-sm-12 col-md-12 col-lg-12">
        <h2 class="inner_title">Stepwise approach to control symptoms and minimize future risk</h2>
    </div>
    
    <div class="col-xs-12 col-sm-12 col-md-12 col-lg-12 s2_figure">
        <img src="images/figure.png">
    </div>
    
    <div class="col-xs-12 col-sm-12 col-md-12 col-lg-12 ">
        <p class="paragraph">
ICS= Inhaled glucocorticosteroids. LABA: long acting beta 2 agonist. Med: medium dose. OCS: oral corticosteroid. Anti IgE: anti-immunoglobulin E therapy.<br />
* For children 6-11 years; Theophylline is not recommended, and the preferred step 3 treatment is medium dose ICS.<br />
**Low dose ICS/formoterol is the reliever medication needed for patients prescribed low dose budesonide /formeterol or low dose beclometasone/ formoterol maintenance and reliever therapy. <br />
<br />
1. Global Initiative for Asthma. Global strategy for asthma management and prevention. Revised 2014.
        </p>
    </div>

</body>
</html>
 